Cite
HARVARD Citation
Rivas, A. et al. (2022). Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study. BMJ open. 12 (3), p. . [Online].